Abraxane
Term · Oncology and biomedicine · MLC-T-ONC-000110
A form of the anticancer drug paclitaxel that is used alone or with other drugs to treat certain types of breast cancer, non-small cell lung cancer, and pancreatic cancer. Abraxane may have fewer side effects and work better than other forms of paclitaxel. It is also being studied in the treatment of other types of cancer. Abraxane stops cancer cells from growing and dividing and may kill them. It is a type of taxane. Also called ABI-007, nanoparticle paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation, and protein-bound paclitaxel.
| Identifier | MLC-T-ONC-000110 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ABI-007; nanoparticle paclitaxel; paclitaxel albumin-stabilized nanoparticle formulation; protein-bound paclitaxel |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000110",
"term": "Abraxane",
"field": "Oncology and biomedicine",
"definition": "A form of the anticancer drug paclitaxel that is used alone or with other drugs to treat certain types of breast cancer, non-small cell lung cancer, and pancreatic cancer. Abraxane may have fewer side effects and work better than other forms of paclitaxel. It is also being studied in the treatment of other types of cancer. Abraxane stops cancer cells from growing and dividing and may kill them. It is a type of taxane. Also called ABI-007, nanoparticle paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation, and protein-bound paclitaxel.",
"synonyms": [
"ABI-007",
"nanoparticle paclitaxel",
"paclitaxel albumin-stabilized nanoparticle formulation",
"protein-bound paclitaxel"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/abraxane/"
}
Record 186 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.